Trends in Testing of Serum Creatinine and Albuminuria
The prevalence of patients receiving testing for serum creatinine, lipid levels, and urine albumin to creatinine ratio among commercially insured patients with diagnosed CKD has increased over the years. Testing rates were higher in older age groups and for patients with diabetes or hypertension. Patients with CKD stages 3 and 4 were more likely to receive all three tests. Explore the detailed trends based on age, sex, and race/ethnicity.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
Trends in Testing of Serum Creatinine, Albuminuria, and Trends in Testing of Serum Creatinine, Albuminuria, and Lipid Levels among Commercially Insured Patients with Lipid Levels among Commercially Insured Patients with Diagnosed CKD Diagnosed CKD The prevalence of patients receiving testing for serum creatinine, lipid levels, and urine albumin to creatinine ratio during the same calendar year was 15.1% in 2007 and 27.7% in 2020. Prevalence of testing was more common in older age groups and was more than twice as high for patients with than without diabetes. Patients with hypertension were approximately twice as likely to receive all three tests than those without hypertension. Patients with CKD stages 3 and 4 tended to have a higher prevalence of receiving all three tests. Data Source: Clinformatics Commercial https://nccd.cdc.gov/CKD/detail.aspx?Qnum=Q789
Trends in Testing of Serum Creatinine, Albuminuria, and Trends in Testing of Serum Creatinine, Albuminuria, and Lipid Levels among Commercially Insured Patients with Lipid Levels among Commercially Insured Patients with Diagnosed CKD, Overall Diagnosed CKD, Overall 35 Combined Testing (%) 30 25 20 15 10 5 0
Trends in Testing of Serum Creatinine, Albuminuria, and Trends in Testing of Serum Creatinine, Albuminuria, and Lipid Levels among Commercially Insured Patients with Lipid Levels among Commercially Insured Patients with Diagnosed CKD, by Age Diagnosed CKD, by Age 35 Combined Testing (%) 30 25 20 15 10 5 0 Overall 20 29 years 30 39 years 40 49 years 50 59 years 60 69 years 70+ years
Trends in Testing of Serum Creatinine, Albuminuria, and Trends in Testing of Serum Creatinine, Albuminuria, and Lipid Levels among Commercially Insured Patients with Lipid Levels among Commercially Insured Patients with Diagnosed CKD, by Sex Diagnosed CKD, by Sex 35 Combined Testing (%) 30 25 20 15 10 5 0 Overall Female Male
Trends in Testing of Serum Creatinine, Albuminuria, and Trends in Testing of Serum Creatinine, Albuminuria, and Lipid Levels among Commercially Insured Patients with Lipid Levels among Commercially Insured Patients with Diagnosed CKD, by Race/Ethnicity Diagnosed CKD, by Race/Ethnicity 40 Combined Testing (%) 35 30 25 20 15 10 5 0 Overall Asian Black Hispanic Unknown White
Trends in Testing of Serum Creatinine, Albuminuria, and Trends in Testing of Serum Creatinine, Albuminuria, and Lipid Levels among Commercially Insured Patients with Lipid Levels among Commercially Insured Patients with Diagnosed CKD, by CKD Stage Diagnosed CKD, by CKD Stage 40 Combined Testing (%) 35 30 25 20 15 10 5 0 Overall CKD Stage 1 CKD Stage 2 CKD Stage 3 CKD Stage 4 CKD Stage 5 Unknown
Trends in Testing of Serum Creatinine, Albuminuria, and Trends in Testing of Serum Creatinine, Albuminuria, and Lipid Levels among Commercially Insured Patients with Lipid Levels among Commercially Insured Patients with Diagnosed CKD, by Diabetes Diagnosed CKD, by Diabetes 50 Combined Testing (%) 40 30 20 10 0 Overall With Diabetes Without Diabetes
Trends in Testing of Serum Creatinine, Albuminuria, and Trends in Testing of Serum Creatinine, Albuminuria, and Lipid Levels among Commercially Insured Patients with Lipid Levels among Commercially Insured Patients with Diagnosed CKD, by Hypertension Diagnosed CKD, by Hypertension 35 Combined Testing (%) 30 25 20 15 10 5 0 Overall With Hypertension Without Hypertension
